BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33149672)

  • 1. CYLD Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating NDRG1.
    Lin Y; Wang L; Luo W; Zhou X; Chen Y; Yang K; Liao J; Wu D; Cai L
    Cancer Manag Res; 2020; 12():10639-10649. PubMed ID: 33149672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma.
    Deng M; Dai W; Yu VZ; Tao L; Lung ML
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.
    Zhang J; Wen X; Liu N; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Zhang PP; Ma J; Sun Y
    J Exp Clin Cancer Res; 2017 Oct; 36(1):147. PubMed ID: 29052525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYLD deficiency enhances metabolic reprogramming and tumor progression in nasopharyngeal carcinoma via PFKFB3.
    Wang L; Lin Y; Zhou X; Chen Y; Li X; Luo W; Zhou Y; Cai L
    Cancer Lett; 2022 Apr; 532():215586. PubMed ID: 35131382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PVT1 Mediates Cell Proliferation, Apoptosis and Radioresistance in Nasopharyngeal Carcinoma Through Regulating miR-515-5p/PIK3CA Axis.
    Han Y; Li F; Xie J; Wang Y; Zhang H
    Cancer Manag Res; 2020; 12():10077-10090. PubMed ID: 33116864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircPSMC3 inhibits cell proliferation and induces cell apoptosis in nasopharyngeal carcinoma by downregulating ROCK1.
    Guo DQ; Liu F; Zhang L; Bian NN; Liu LY; Kong LX; Wang ZG
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1219-1225. PubMed ID: 32096151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
    Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogen-induced super-enhancer RNA promotes nasopharyngeal carcinoma metastasis through NPM1/c-Myc/NDRG1 axis.
    Jia Q; Deng H; Wu Y; He Y; Tang F
    Am J Cancer Res; 2023; 13(8):3781-3798. PubMed ID: 37693164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
    Luo XY; Yan B; Cai CF; Chen AM; Zhou M
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR‑181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF‑κB signaling pathway.
    Yang X; Sun Y; Zhang Y; Han S
    Int J Mol Med; 2020 Nov; 46(5):1755-1764. PubMed ID: 32901872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
    Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma.
    Zhang JP; Zhang H; Wang HB; Li YX; Liu GH; Xing S; Li MZ; Zeng MS
    J Transl Med; 2014 Aug; 12():222. PubMed ID: 25099028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma.
    Huang DH; Wang GY; Zhang JW; Li Y; Zeng XC; Jiang N
    Jpn J Clin Oncol; 2015 Aug; 45(8):738-44. PubMed ID: 25917358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAI1 overexpression promotes apoptosis and inhibits proliferation, cell cycle, migration, and invasion in nasopharyngeal carcinoma cells.
    Guo Z; Wang Y; Yang J; Zhong J; Liu X; Xu M
    Am J Otolaryngol; 2017; 38(5):511-517. PubMed ID: 28583320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer.
    Huang Y; Zhang W; Yu Z; Su H; Zeng B; Piao J; Wang J; Wu J
    Clin Med Insights Oncol; 2023; 17():11795549231180832. PubMed ID: 37359274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeic Acid Phenethyl Ester Induces
    Chiang KC; Yang SW; Chang KP; Feng TH; Chang KS; Tsui KH; Shin YS; Chen CC; Chao M; Juang HH
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
    Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.